C12N 2740/10044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2740/10044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 3
- Assignees
- 1
- Inventors
- 1
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modified HIV-1 proviral vectors with enhanced dendritic cell transduction efficiencies comprising the JRFL envelope23 Dec 2025US 12,503,499 B2University of Massachusetts
- Generation of human anti-HIV-1 ENV monoclonal antibodies with neutralizing activity from humanized mice infected with HIV-112 Oct 2021US 11,142,566 B2University of Massachusetts
- Use of modified hiv-1 for generating fully human antibodies2 Jul 2026US 2026/0184767 A1University of Massachusetts
- Use of modified hiv-1 for generating fully human antibodies7 Apr 2022US 2022/0106385 A1University of Massachusetts
- Use of modified hiv-1 for generating fully human antibodies28 Feb 2019US 2019/0062409 A1University of Massachusetts
Most cited
By later US patents